ClinicalTrials.gov
public full text
Public Domain
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease Manifestations
To study the safety and possible side effects of using the imaging agent 4-\[18F\]Fluoro-1-Naphthol (also called \[18F\]4FN) in PET/CT scans for participants with chronic GVHD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor#802416
- Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients#903232
- [(18)F]Fluorodeoxyglucose positron emission tomography ([(18)F]FDG PET) Characterizes Neurodegeneration Levels Across the α-Synucleinopathy Continuum.#396054
- Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging#1095530
- Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell Arteritis#917881
Record · ID 898331
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive